A hemolysin secretion pathway-based novel secretory expression platform for efficient manufacturing of tag peptides and anti-microbial peptides in Escherichia coli

Abstract

Background

Although Escherichia coli has been widely used for the expression of exogenous proteins, the secretory expression in this system is still a big obstacle. As one of the most important secretion pathways, hemolysin A (HlyA) system of E. coli can transport substrates directly from the cytoplasm to extracellular medium without the formation of any periplasmic intermediate, making it an ideal candidate for the development of the secretory production platform for exogenous proteins.

Results

In this work, we developed a novel production platform, THHly, based on the HlyA secretion system, and explored its applications in the efficient preparation and quick detection of tag peptides and anti-microbial peptides. In this novel platform the signal sequence of HlyA is fused to the C-terminal of target peptide, with Tobacco Etch Virus (TEV) protease cleavage site and 6*His tag between them. Five tag peptides displayed good secretory properties in E. coli BL21 (DE3), among which T7 tag and S tag were obtained by two rounds of purification steps and TEV cleavage, and maintained their intrinsic immunogenicity. Furthermore, Cecropin A and Melittin, two different types of widely explored anti-microbial peptides, were produced likewise and verified to possess anti-microbial/anti-tumor bioactivities. No significant bacterial growth inhibition was observed during the fusion protein expression, indicating that the fusion form not only mediated the secretion but also decreased the toxicity of anti-microbial peptides (AMPs) to the host bacteria. To the best of our knowledge, this is the first report to achieve the secretory expression of these two AMPs in E. coli with considerable potential for manufacturing and industrialization purposes.

Conclusions

The results demonstrate that the HlyA based novel production platform of E. coli allowed the efficient secretory production and purification of peptides, thus suggesting a promising strategy for the industrialized production of peptide pharmaceuticals or reagents.

Keywords

E. coli / Hemolysin A / Secretory expression / Tag peptides / Anti-microbial peptides

References

[1] Agrawal A, Weisshaar JC. Effects of alterations of the E. coli lipopolysaccharide layer on membrane permeabilization events induced by Cecropin A. Biochim Biophys Acta Biomembr, 2018, 1860(7): 1470-1479.

[2] Angkawidjaja C, Kuwahara K, Omori K, Koga Y, Takano K, Kanaya S. Extracellular secretion of Escherichia coli alkaline phosphatase with a C-terminal tag by type I secretion system: purification and biochemical characterization. Protein Eng Des Sel, 2006, 19(7): 337-343.

[3] Bakkes PJ, Jenewein S, Smits SH, Holland IB, Schmitt L. The rate of folding dictates substrate secretion by the Escherichia coli hemolysin type 1 secretion system. J Biol Chem, 2010, 285(52): 40573-40580.

[4] Bechinger B, Gorr SU. Antimicrobial peptides: mechanisms of action and resistance. J Dent Res, 2017, 96(3): 254-260.

[5] Burdette LA, Leach SA, Wong HT, Tullman-Ercek D. Developing Gram-negative bacteria for the secretion of heterologous proteins. Microb Cell Fact, 2018, 17(1): 196.

[6] Carmignotto GP, Azzoni AR. On the expression of recombinant Cas9 protein in E. coli BL21(DE3) and BL21(DE3) Rosetta strains. J Biotechnol, 2019, 306: 62-70.

[7] Chen QC, Liu L, Yu TY, . High-level expression and purification of melittin in Escherichia coli using SUMO fusion partner. Int J Pept Res Ther, 2021, 27: 9-15.

[8] Chervaux C, Sauvonnet N, Le Clainche A, Kenny B, Hung AL, Broome-Smith JK, Holland IB. Secretion of active beta-lactamase to the medium mediated by the Escherichia coli hemolysin transport pathway. Mol Gen Genet, 1995, 249(2): 237-245.

[9] Feilmeier BJ, Iseminger G, Schroeder D, . Green fluorescent protein functions as a reporter for protein localization in Escherichia coli. J Bacteriol, 2000, 182(14): 4068-4076.

[10] Fernández LA, Sola I, Enjuanes L, de Lorenzo V. Specific secretion of active single-chain Fv antibodies into the supernatants of Escherichia coli cultures by use of the hemolysin system. Appl Environ Microbiol, 2000, 66(11): 5024-5029.

[11] Fraile S, Muñoz A, de Lorenzo V, Fernández LA. Secretion of proteins with dimerization capacity by the haemolysin type I transport system of Escherichia coli. Mol Microbiol, 2004, 53(4): 1109-1121.

[12] Freudl R. Signal peptides for recombinant protein secretion in bacterial expression systems. Microb Cell Fact, 2018, 17(1): 52.

[13] Fry DE. Antimicrobial peptides. Surg Infect, 2018, 19(8): 804-811.

[14] Greber KE, Dawgul M. Antimicrobial peptides under clinical trials. Curr Top Med Chem, 2017, 17(5): 620-628.

[15] Hayat SMG, Farahani N, Golichenari B, Sahebkar A. Recombinant protein expression in Escherichia coli (E. coli): what we need to know. Curr Pharm Des, 2018, 24(6): 718-725.

[16] Hou H, Zhang Z, Zhao W, Hou J. Generating DNA sequences encoding tandem peptide repeats suitable for expression and immunological application. World J Microbiol Biotechnol, 2012, 28(5): 2175-2180.

[17] Jeon J, Thurber KR, Ghirlando R, Yau WM, Tycko R. Application of millisecond time-resolved solid state NMR to the kinetics and mechanism of melittin self-assembly. Proc Natl Acad Sci USA, 2019, 116(34): 16717-16722.

[18] Kanonenberg K, Spitz O, Erenburg IN, Beer T, Schmitt L. Type I secretion system-it takes three and a substrate. FEMS Microbiol Lett, 2018, 365(11

[19] Kanonenberg K, Smits SHJ, Schmitt L. Functional reconstitution of HlyB, a type I secretion ABC transporter, in Saposin-A nanoparticles. Sci Rep, 2019, 9(1): 8436.

[20] Kaur J, Kumar A, Kaur J. Strategies for optimization of heterologous protein expression in E. coli: roadblocks and reinforcements. Int J Biol Macromol, 2018, 106: 803-822.

[21] Kern I, Cegłowski P. Secretion of streptokinase fusion proteins from Escherichia coli cells through the hemolysin transporter. Gene, 1995, 163(1): 53-57.

[22] Khosa S, Scholz R, Schwarz C, Trilling M, Hengel H, Jaeger KE, Smits SHJ, Schmitt L. An A/U-rich enhancer region is required for high-level protein secretion through the HlyA type I secretion system. Appl Environ Microbiol, 2017, 84(1): e01163-e1217.

[23] Kim JS, Song S, Lee M, Lee S, Lee K, Ha NC. Crystal structure of a soluble fragment of the membrane fusion protein HlyD in a type I secretion system of Gram-negative bacteria. Structure, 2016, 24(3): 477-485.

[24] Linton E, Walsh MK, Sims RC, Miller CD. Translocation of green fluorescent protein by comparative analysis with multiple signal peptides. Biotechnol J, 2012, 7(5): 667-676.

[25] Mahlapuu M, Håkansson J, Ringstad L, Björn C. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol, 2016, 6: 194.

[26] Memariani H, Memariani M, Shahidi-Dadras M, Nasiri S, Akhavan MM, Moravvej H. Melittin: from honeybees to superbugs. Appl Microbiol Biotechnol, 2019, 103(8): 3265-3276.

[27] Natale P, Brüser T, Driessen AJ. Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane–distinct translocases and mechanisms. Biochim Biophys Acta, 2008, 1778(9): 1735-1756.

[28] Nicaud JM, Mackman N, Gray L, Holland IB. The C-terminal, 23 kDa peptide of E. coli haemolysin 2001 contains all the information necessary for its secretion by the haemolysin (Hly) export machinery. FEBS Lett, 1986, 204(2): 331-335.

[29] Nielsen JE, Bjørnestad VA, Pipich V, Jenssen H, Lund R. Beyond structural models for the mode of action: how natural antimicrobial peptides affect lipid transport. J Colloid Interface Sci, 2021, 582(Pt B): 793-802.

[30] Nuti R, Goud NS, Saraswati AP, Alvala R, Alvala M. Antimicrobial peptides: a promising therapeutic strategy in tackling antimicrobial resistance. Curr Med Chem, 2017, 24(38): 4303-4314.

[31] Otvos L Jr. Immunomodulatory effects of anti-microbial peptides. Acta Microbiol Immunol Hung, 2016, 63(3): 257-277.

[32] Park AR, Jang SW, Kim JS, Park YG, Koo BS, Lee HC. Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E. coli. PLoS ONE, 2018, 13(7

[33] Rangarajan N, Bakshi S, Weisshaar JC. Localized permeabilization of E. coli membranes by the antimicrobial peptide Cecropin A. Biochemistry, 2013, 52(38): 6584-6594.

[34] Ruano-Gallego D, Fraile S, Gutierrez C, Fernández LÁ. Screening and purification of nanobodies from E. coli culture supernatants using the hemolysin secretion system. Microb Cell Fact, 2019, 18(1): 47.

[35] Sang M, Zhang J, Zhuge Q. Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells. Eur J Pharmacol, 2017, 803: 138-147.

[36] Schwarz CK, Lenders MH, Smits SH, Schmitt L. Secretion of slow-folding proteins by a type 1 secretion system. Bioengineered, 2012, 3(5): 289-292.

[37] Schwarz CK, Landsberg CD, Lenders MH, Smits SH, Schmitt L. Using an E. coli type 1 secretion system to secrete the mammalian, intracellular protein IFABP in its active form. J Biotechnol, 2012, 159(3): 155-161.

[38] Spitz O, Erenburg IN, Beer T, Kanonenberg K, Holland IB, Schmitt L. Type I secretion systems-one mechanism for all?. Microbiol Spectr, 2019

[39] Thomas S, Bakkes PJ, Smits SH, Schmitt L. Equilibrium folding of pro-HlyA from Escherichia coli reveals a stable calcium ion dependent folding intermediate. Biochim Biophys Acta, 2014, 1844(9): 1500-1510.

[40] Thomas S, Holland IB, Schmitt L. The type 1 secretion pathway—the hemolysin system and beyond. Biochim Biophys Acta, 2014, 1843(8): 1629-1641.

[41] Wakasa A, Kaneko MK, Kato Y, Takagi J, Arimori T. Site-specific epitope insertion into recombinant proteins using the MAP tag system. J Biochem, 2020, 168(4): 375-384.

[42] Wang M, Huang M, Zhang J, Ma Y, Li S, Wang J. A novel secretion and online-cleavage strategy for production of cecropin A in Escherichia coli. Sci Rep, 2017, 7(1): 7368.

[43] Wang M, Zheng K, Lin J, Huang M, Ma Y, Li S, Luo X, Wang J. Rapid and efficient production of cecropin A antibacterial peptide in Escherichia coli by fusion with a self-aggregating protein. BMC Biotechnol, 2018, 18(1): 62.

[44] Wang M, Lin J, Sun Q, Zheng K, Ma Y, Wang J. Design, expression, and characterization of a novel cecropin A-derived peptide with high antibacterial activity. Appl Microbiol Biotechnol, 2019, 103(4): 1765-1775.

[45] Wei X, Wu R, Zhang L, Ahmad B, Si D, Zhang R. Expression, purification, and characterization of a novel hybrid peptide with potent antibacterial activity. Molecules, 2018, 23(6): 1491.

[46] Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc, 2008, 3(2): 163-175.

[47] Xi X, Li X, Wu F, Guan X, Jin L, Guo Y, Song W, Du B. Expression, purification and characterization of active untagged recombinant human leukemia inhibitory factor from E. coli. Protein Expr Purif, 2017, 134: 139-146.

[48] Xu X, Jin F, Yu X, Ji S, Wang J, Cheng H, Wang C, Zhang W. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli. Protein Expr Purif, 2007, 53(2): 293-301.

[49] Yin Y, Zhang F, Ling V, Arrowsmith CH. Structural analysis and comparison of the C-terminal transport signal domains of hemolysin A and leukotoxin A. FEBS Lett, 1995, 366(1): 1-5.

Funding

Science and Technology Commission of Shanghai Municipality(No. 21S11906300)